As many of you know, I’m currently studying to become a Certified Diabetes Educator. So I was delighted to have the opportunity to attend the American Diabetes Association’s annual Advanced Postgraduate Course in New York City on Feb. 23 — a two-and-a-half-day conference that can be viewed as the ‘little sister’ to the ADA’s huge Scientific Sessions held each summer.
This Postgraduate event hosts just a few hundred doctors, pharmacists, diabetes educators, dieticians and other healthcare…
Read more »
In most areas of diabetes research, you don’t hear much until there’s a big breakthrough of some sort. And then it goes dark again.
That’s what happened several years ago on the then-hot topic of xenotransplantation, or the sourcing of islet cells for transplants. Some studies were launched using porcine cells and the press had a field day with headlines like “pig sushi diabetes trial.” Since then? Nada.
But recently, a New Zealand-based company called…
Read more »
While on a recent trip to Boston, I was fortunate to have the opportunity to sit down for a chat with Dr. Denise Faustman, one of the many diabetes researchers on the quest to find a cure for diabetes. Dr. Faustman’s research has been hotly debated for the past several years, and because of that, much of the research has been funded through private donations.
We last spoke with Dr. Faustman almost two years ago,…
Read more »
With all the talk about mice in cure research (over 2 million results for “mice diabetes research” on Google!), you might think there is absolutely no way for you — a human — to participate in the magic of modern science. But there are actually a lot of studies going on right now that need participation from PWDs with both type 1 and type 2 diabetes.
Worried about risking your health on something too experimental? …
Read more »
By
AmyT on
January 24, 2011
I can’t help it. This reminds me of the movie City Slickers, in which one of the characters has messed up his life, and his friends tell him he’s getting a “do-over.” The young company Dance Pharmaceuticals, based in downtown San Francisco, is basically on a mission to salvage the good parts of Pfizer’s failed inhaled insulin Exubera (not the awkward delivery device!) and launch a second coming of the base product that is “simpler,…
Read more »
